methotrexate has been researched along with Hepatitis E in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hooda, P; Khatter, R; Kumar, A; Parvez, MK; Puri, A; S Al-Dosari, M; Sehgal, D; Sinha, N | 1 |
| Conway, R; Cunnane, G; Dalton, B | 1 |
| Agarwal, A; Guleria, S; Jindal, AK; Naseem, S; Ratho, RK; Sharma, S; Singh, MP; Suri, D | 1 |
| Ledeboer, M; Martens, HA; van Bijnen, ST | 1 |
4 other study(ies) available for methotrexate and Hepatitis E
| Article | Year |
|---|---|
Methotrexate, an anti-inflammatory drug, inhibits Hepatitis E viral replication.
Topics: Anti-Inflammatory Agents; Hepatitis E; Hepatitis E virus; Humans; Methotrexate; Virus Replication | 2023 |
Acute hepatitis E in an immunocompromised patient with seropositive rheumatoid arthritis on rituximab and long-term methotrexate.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Hepatitis E; Humans; Immunocompromised Host; Methotrexate; Middle Aged; Rituximab | 2021 |
Adult-Onset Still Disease and Macrophage Activation Syndrome Following Chikungunya and Hepatitis E Coinfection.
Topics: Adolescent; Antirheumatic Agents; Chikungunya Fever; Chikungunya virus; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin M; Macrophage Activation Syndrome; Methotrexate; Prednisolone; Serologic Tests; Still's Disease, Adult-Onset; Treatment Outcome | 2018 |
Chronic hepatitis E in a patient with rheumatoid arthritis treated with adalimumab and methotrexate.
Topics: Adalimumab; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Hepatitis E; Hepatitis, Chronic; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Ribavirin | 2017 |